VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
This Quarter Return
+3.07%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$1.62M
AUM Growth
+$1.62M
(-100%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-7,850.43%
Top 10 Holdings %
Top 10 Hldgs %
16.56%
Holding
402
New
38
Increased
331
Reduced
2
Closed
31
Top Buys
| 1 |
Elbit Systems
ESLT
|
$181K |
| 2 |
Amazon
AMZN
|
$12.6K |
| 3 |
Microsoft
MSFT
|
$9.56K |
| 4 |
AGN
Allergan plc
AGN
|
$6.81K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$6.66K |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$91.8M |
| 2 |
HNT
HEALTH NET INC
HNT
|
$2.13M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$1.93M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.48M |
| 5 |
Duke Energy
DUK
|
$1.47M |
Sector Composition
| 1 | Industrials | 19.96% |
| 2 | Technology | 12.84% |
| 3 | Financials | 11.72% |
| 4 | Healthcare | 11.37% |
| 5 | Consumer Discretionary | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LCI
326
DELISTED
Lannett Company, Inc.
LCI
| $1.81K | 0.11% |
100,682
+48,905
| +94% | +$877 |
|
327
Azenta
AZTA
$1.35B
| $1.8K | 0.11% |
173,210
+81,007
| +88% | +$843 |
|
328
Angi Inc
ANGI
$795M
| $1.8K | 0.11% |
+222,644
| New | +$1.8K |
|
|
ASXC
329
DELISTED
Asensus Surgical, Inc.
ASXC
| $1.79K | 0.11% |
420,650
+19,802
| +5% | +$84 |
|
|
VTA
330
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
| $1.78K | 0.11% |
166,004
+84,888
| +105% | +$912 |
|
|
FLIR
331
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $1.78K | 0.11% |
54,046
+18,803
| +53% | +$619 |
|
332
Deere & Co
DE
$127B
| $1.75K | 0.11% |
22,786
+9,550
| +72% | +$735 |
|
333
Merck
MRK
$211B
| $1.73K | 0.11% |
32,696
+17,309
| +112% | +$916 |
|
334
Pfizer
PFE
$141B
| $1.66K | 0.1% |
56,146
+29,367
| +110% | +$870 |
|
335
Icon
ICLR
$14.1B
| $1.66K | 0.1% |
22,108
+11,874
| +116% | +$892 |
|
336
Ferrari
RACE
$87.8B
| $1.63K | 0.1% |
+39,350
| New | +$1.63K |
|
337
PNC Financial Services
PNC
$80.2B
| $1.49K | 0.09% |
17,566
+8,246
| +88% | +$698 |
|
|
FPRX
338
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.43K | 0.09% |
35,296
+16,412
| +87% | +$667 |
|
339
Nuveen Preferred & Income Opportunities Fund
JPC
$2.61B
| $1.43K | 0.09% |
153,060
+78,264
| +105% | +$732 |
|
|
CLLS
340
Cellectis
CLLS
$261M
| $1.37K | 0.08% |
49,870
+23,273
| +88% | +$640 |
|
341
Novartis
NVS
$248B
| $1.37K | 0.08% |
18,860
+9,853
| +109% | +$714 |
|
342
Xencor
XNCR
$587M
| $1.35K | 0.08% |
100,866
+48,268
| +92% | +$648 |
|
|
AGEN
343
Agenus
AGEN
$135M
| $1.34K | 0.08% |
321,178
+149,884
| +88% | +$624 |
|
344
AstraZeneca
AZN
$254B
| $1.28K | 0.08% |
45,534
+21,727
| +91% | +$612 |
|
|
ADXS
345
DELISTED
Advaxis, Inc.
ADXS
| $1.25K | 0.08% |
137,912
+64,359
| +88% | +$581 |
|
|
CELG
346
DELISTED
Celgene Corp
CELG
| $1.17K | 0.07% |
11,730
+5,435
| +86% | +$544 |
|
|
JUNO
347
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.15K | 0.07% |
30,320
+14,071
| +87% | +$536 |
|
|
ADAP
348
Adaptimmune Therapeutics
ADAP
$14.6M
| $1.15K | 0.07% |
141,086
+65,546
| +87% | +$533 |
|
349
Alaunos Therapeutics
TCRT
$4.41M
| $1.1K | 0.07% |
148,806
+71,201
| +92% | +$528 |
|
|
BLUE
350
DELISTED
bluebird bio
BLUE
| $976 | 0.06% |
22,946
+10,661
| +87% | +$453 |
|